Copeland, HannahBaran, David A.Morton, JohnRodriguez, VicenteFernandes, EustaceMohammed, Asim2023-10-312023-10-312023Copeland H, Baran DA, Morton J, Rodriguez V, Fernandes E, Mohammed A. Veno-venous ECLS rescue for a heart transplant recipient with COVID-19, a case report [published online ahead of print, 2023 Jan 30]. Perfusion. 2023;2676591231154120. doi:10.1177/02676591231154120https://hdl.handle.net/1805/36804The potential for increased rates of morbidity of SARS-CoV-2 within immunocompromised populations has been of concern since the pandemic’s onset. Transplant providers and patients can face particularly challenging situations, in the current settings as data continues to emerge for the prevention and treatment of the immunocompromised subpopulation. This case report details a patient 9-months post orthotopic heart transplant that developed SARS-CoV-2 infection despite two prior doses of the Pfizer-BioNtech COVID-19 vaccine, and had successful rescue from refractory hypoxemia with veno-venous extracorporeal membrane oxygenation (VV ECLS).en-USPublisher PolicyExtracorporeal membrane oxygenationHeart transplantAcute respiratory distress syndromeCOVID-19ImmunocompromisedExtracorporeal life supportArticle